case based panel discussion nsclc – does a positive her2 mutation effect treatment decisions?
Published 4 years ago • 71 plays • Length 6:29Download video MP4
Download video MP3
Similar videos
-
7:19
case based panel discussion 2.7 clinical significance of her2 mutation how does a positive her2 muta
-
12:59
case based panel discussion - adv non squamous nsclc, low pd-l1 no mutation - best systemic therapy?
-
6:18
treating her2 exon-20 insertion nsclc with trastuzumab deruxtecan - case based panel discussion
-
6:15
treatment options for egfr nsclc - case based panel discussion
-
3:45
case based panel discussion - egfr mutation and tagrisso - progression & the role of repeat biopsy
-
6:00
case based panel discussions - egfr mutation & met - treatment decisions, level of met amplification
-
6:52
case based panel discussion - egfr mutation with met amplification treatment decisions and the impor
-
4:10
how oncologists stage disease - case based panel discussion
-
6:10
case based panel discussion - what is the recommended treatment for common egfr mutations
-
5:18
case based panel discussion - egfr mutation -the recommended treatment for common egfr mutations
-
7:30
case based panel discussions - egfr mutation and flaura trial - demographics, effect on treatment?
-
11:25
case based panel discussion - stage3 nsclc should we do molecular tests? effect treatment decision?
-
5:39
non-bulky nsclc 2b disease: the role of chemoimmunotherapy - case based panel discussion
-
8:20
case based panel discussion - egfr - progression, next steps - a place for chemo & immunotherapy? v2
-
5:52
case based panel discussion - egfr - exon 20 mutation, treatment, targeted therapy, clinical trials
-
6:31
gracecast - treatment options for patients with advanced nsclc and a her2- erbb2 mutation
-
7:12
egfr mutated adenocarcinoma - case based panel discussions